XML 62 R34.htm IDEA: XBRL DOCUMENT v3.25.4
Stock Options (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount
Stock-based compensation expense recognized for options was as follows:
For the Years Ended December 31,
2025
2024
Research and development
$
1,351 
$
2,505 
General and administrative
61,393 
242,548 
Total
$
62,744 
$
245,053 
Schedule of Options Outstanding and Exercisable
The following table summarizes information about options outstanding and exercisable at December 31, 2025:
Options Outstanding
Options Exercisable
Exercise Price
Number of Options at December 31, 2025
Weighted Average Remaining Contractual Life
Weighted Average Exercise Price
Number of Options at December 31, 2025
Weighted Average Remaining Contractual Life
Weighted Average Exercise Price
$
0.29 
134,084 
10.0 years
$
0.29 
33,440 
10.0 years
$
0.29 
$
95.38 
1,030 
0.0 years
$
95.38 
1,030 
0.0 years
$
95.38 
$
185.15 
609 
0.0 years
$
185.15 
609 
0.0 years
$
185.15 
$
340.20 
3,999 
3.8 years
$
340.20 
3,999 
3.8 years
$
340.20 
$
413.59 
200 
7.7 years
$
413.59 
118 
7.7 years
$
413.59 
139,922 
39,196 
Schedule of Stock Option Activity
Total stock option activity for the year ended December 31, 2025, is summarized as follows:
Options
Weighted Average Exercise Price
Weighted Average Remaining Contractual Term (years)
Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2024
6,237 
$
277.06 
3.7 years
— 
Granted
134,084 
— 
Exercised
— 
— 
Forfeited
(399)
— 
Outstanding at December 31, 2025
139,922 
$
12.10 
9.7 years
— 
Vested and Exercisable at December 31, 2025
39,196 
41.58
8.9 years
—